Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|June 28, 2025
Circulating gene expression assay as a diagnostic and prognostic biomarker for pancreatic neuroendocrine tumours in MEN1Eline N M van Vliembergen, Mark J C van Treijen, Rachel S van Leeuwaarde, et al.
Medicine|July 23, 2015
Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2: Retrospective Cohort AnalysisWouter P Kluijfhout, Dirk-Jan van Beek, Annemarie A Verrijn Stuart, et al.
Frontiers in Endocrinology|December 20, 2018
Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation StudyMark J C van Treijen, Catharina M Korse, Rachel S van Leeuwaarde, et al.
European Journal of Endocrinology|May 15, 2012
Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumorsJoanne M de Laat, Emma Tham, Carolina R C Pieterman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2021
Well-Differentiated Bronchopulmonary Neuroendocrine Tumors: More Than One EntityMedard F M van den Broek, Sonja Levy, Wieneke A Buikhuisen, et al.
Molecular and Cellular Endocrinology|September 5, 2009
Regulation of vitamin D receptor function in MEN1-related parathyroid adenomasKoen M A Dreijerink, Radhika A Varier, Rick van Nuland, et al.
Endocrine Research|May 17, 2017
Follow-up of patients with thyroglobulin-antibodies: Rising Tg-Ab trend is a risk factor for recurrence of differentiated thyroid cancerSiegrid G A de Meer, Wessel M C M Vorselaars, Jakob W Kist, et al.
Surgery|June 4, 2025
Partial adrenalectomy for pheochromocytoma in the multiple endocrine neoplasia type 2 population: Time to reconsider?Diederik P D Suurd, Medard F M Van den Broek, Charlotte L Viëtor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
Genome Methylation Accurately Predicts Neuroendocrine Tumor Origin: An Online ToolWenzel M Hackeng, Koen M A Dreijerink, Wendy W J de Leng, et al.
EJNMMI Research|March 8, 2020
<sup>68</sup>Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with <sup>177</sup>Lu-PSMA-617Lisa H de Vries, Lutske Lodewijk, Arthur J A T Braat, et al.
Pageof 14